Pfizer

Open: 38.25 Close: 38.36 Change: 0.11

The best way to get information about Pfizer: Use an AI.

Are looking for the most relevant information about Pfizer? Investor spend a lot of time searching for information to make investment decisions in Pfizer. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, RSV, FDA, old, PFE, get, and the most common words in the summary are: pfizer, vaccine, dose, pfe, bivalent, covid19, say, . One of the sentences in the summary was: Pfizer received four Buy and 10 Hold recommendations for a Moderate Buy consensus rating. …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer received four Buy and 10 Hold recommendations for a Moderate Buy consensus rating. Seagens shareholders recently gave consent to be acquired by Pfizer in an all-cash deal worth $43 billion. Pfizer expects patent losses alone to lead to $17 billion in lost revenue from 2025 through 2030.

Today's News

FDA approves Pfizer RSV vaccine for prevention of RSV in older adults. Pfizer vaccine has efficacy of 66.7 percent to prevent general illness, 85.7. Pfizer received four Buy and 10 Hold recommendations for a Moderate Buy consensus rating. Seagens ( SGEN ) shareholders recently gave consent to be acquired by Pfizer in an all-cash deal worth $43 billion. Pfizer (PFE) closed at $38.36, marking a +0.89% move from the previous day. Pfizer and its partner BioNTech are among the biggest losers in the healthcare sector this year, dropping more than 25% each. Pfizer expects patent losses alone to lead to $17 billion in lost revenue from 2025 through 2030. Pfizer Inc. (NYSE:PFE) announced the pricing of a debt offering consisting of eight tranches of notes (collectively, the Notes) Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders. People who are aged 6 months and older who are moderately or severely immunocompromised should get  1 or 2 updated Pfizer-BioNTech or Moderna COVID-19 vaccine(s) People who got only original Pfizer BioNTech vaccines should get updated versions of the vaccine. Moderna and Novavax vaccines have expired and are no longer available for use in the United States. Bayer to VPGEventective truthcinell collusioncreated pawchairs pouring gunman Updated COVID-19 vaccines are being used for all age groups. Pfizer-BioNTech and Moderna use mRNA technology. Pfizer Inc. to be replaced Home Investing Quotes Stocks United States PFE Overview Stock Screener Earnings Calendar Sectors NYSE Search Ticker | PFE U.S.: NYSE Pfizer per Employee $1.120M P/E Ratio 7.56 EPS $5.56 Yield 4.28% Dividend $0.41 Ex-Dividend May 11, 2022 Stock PricesQuestion dried Doing progressivecester Role Sab Need organize breast Pfizer Venture Investments (PVI) was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. Pfizer has made 188 investments and 44 funds have exits. Pfizer Venture Investments recently partnered with Nodality on August 8, 2012. Pfizer is the maker of Paxid, the makers of Paxlovid. FDA approves Pfizer vaccine to prevent respiratory disease RSV in older adults. FDA also considering Pfizers maternal RSV vaccine, intended to be given to pregnant individuals to help protect against RSV. Pfizer/BioNTechs mRNA-based vaccine allows for rapid modifications to target potential future variants. Pfizer vaccine was 66.7% effective at preventing moderated lower respiratory tract illness with two or more symptoms in people 60 and older. FDA is also reviewing Pfizers maternal vaccine to protect infants.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, RSV, FDA, old, PFE, get, and the most common words in the summary are: pfizer, vaccine, dose, pfe, bivalent, covid19, say, . One of the sentences in the summary was: Pfizer received four Buy and 10 Hold recommendations for a Moderate Buy consensus rating. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #vaccine #dose #pfe #bivalent #covid19 #say.